Dopamine in manic depressive illness. A pharmacological synthesis.
about
The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatmentInterpreting magnetic resonance imaging findings in bipolar disorder.Anticonvulsants: aspects of their mechanisms of action.Comparisons of the tolerability and sensitivity of quetiapine-XR in the acute treatment of schizophrenia, bipolar mania, bipolar depression, major depressive disorder, and generalized anxiety disorder.Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET.Dysregulation of the behavioral approach system (BAS) in bipolar spectrum disorders: review of theory and evidence.Psychoendocrinological aspects of affective disorders.Estradiol and lithium chloride specifically alter NMDA receptor subunit NR1 mRNA and excitotoxicity in primary culturesSynaptic and nonsynaptic cross talk between neurons. Role of presynaptic alpha 2-receptors in mental disorders.Tardive dyskinesia in bipolar disorders: possible role of pineal melatonin.Novel nutritional treatment for manic and psychotic disorders: a review of tryptophan and tyrosine depletion studies and the potential of protein-based formulations using glycomacropeptide.Mood-dependent fluctuations in the severity of tardive dyskinesia and psoriasis vulgaris in a patient with schizoaffective disorder: possible role of melatonin.Effect of chronic lithium and withdrawal from chronic lithium on presynaptic dopamine function in the rat.Selective increase of dopamine D3 receptor gene expression as a common effect of chronic antidepressant treatments.Attenuation of some subjective effects of amphetamine following tyrosine depletion.
P2860
Q33593061-FDAD45D2-B006-4BA8-BDDC-34B911AF2301Q34208183-9E9912D4-1805-4D50-95C0-57865693F08CQ34558509-A27FDF04-BDEE-4839-9E5E-D37816D99BCEQ36208776-B26A1D33-7ABE-4ECB-B321-42F7C4EEB157Q36966673-00858ADB-3A43-49AC-8173-D1395901ED47Q37021767-8FDB289D-B162-40DB-9BA6-9A91A0D9379AQ37042366-97DA8F19-6E77-498E-A8D6-EA6BB8B0C646Q37189865-18259488-92DC-4F7A-99ED-29C256E454F1Q37895595-CD0D9ED8-5285-4473-AC8B-3B5CF22FB951Q38018562-7DD715C8-4A67-42EB-B96D-84779C45BAC7Q38119411-627C5664-102C-43F9-9A79-A2720AA80F40Q41216081-4692392A-7ABC-4CA2-8357-92AFEDA23381Q42478147-81199AA9-8DF2-4813-820F-10783E4AE8A8Q52890774-DD1E52EB-190F-4D97-8020-F4933DAF43B4Q52895588-AFCCB49B-25C4-44BC-8F23-819045DBAE35
P2860
Dopamine in manic depressive illness. A pharmacological synthesis.
description
1985 nî lūn-bûn
@nan
1985 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
Dopamine in manic depressive illness. A pharmacological synthesis.
@ast
Dopamine in manic depressive illness. A pharmacological synthesis.
@en
Dopamine in manic depressive illness. A pharmacological synthesis.
@nl
type
label
Dopamine in manic depressive illness. A pharmacological synthesis.
@ast
Dopamine in manic depressive illness. A pharmacological synthesis.
@en
Dopamine in manic depressive illness. A pharmacological synthesis.
@nl
prefLabel
Dopamine in manic depressive illness. A pharmacological synthesis.
@ast
Dopamine in manic depressive illness. A pharmacological synthesis.
@en
Dopamine in manic depressive illness. A pharmacological synthesis.
@nl
P1476
Dopamine in manic depressive illness. A pharmacological synthesis.
@en
P2093
Silverstone T
P304
P356
10.1016/0165-0327(85)90020-5
P577
1985-05-01T00:00:00Z